Endocrine Function after Transsphenoidal Surgery in Patients with Non-Functioning Pituitary Adenomas: A Systematic Review and Meta-Analysis
- PMID: 35172314
- DOI: 10.1159/000522090
Endocrine Function after Transsphenoidal Surgery in Patients with Non-Functioning Pituitary Adenomas: A Systematic Review and Meta-Analysis
Abstract
Introduction: Transsphenoidal surgery is the current treatment for mass reduction in patients with non-functional pituitary adenomas (NFPAs). The surgical procedure may deteriorate or recover pituitary endocrine function. The aim of this study was to systematically assess the benefits and harms of transsphenoidal surgery on pituitary endocrine function in patients with NFPAs.
Methods: This systematic review and meta-analysis was registered with PROSPERO (registration No. CRD42020210853). We searched Pubmed and EMBASE for studies reporting on pituitary function before and after transsphenoidal surgery in patients with NFPAs having a minimum follow-up of 1 month. The prespecified primary outcomes were the proportions of patients with improved or deteriorated pituitary function after surgery reported as weighted mean using random effects meta-analysis or in case of considerable heterogeneity, i.e., I2 ≥ 75%, as a range of reported proportions. Subgroup analyses were planned for the primary outcomes on study level.
Results: Of the 6,597 identified records, 24 studies enrolling 3,816 participants were eligible for assessment. Twenty-three studies were judged to have serious or critical risk of bias. The range of proportions of patients with recovery of at least one pituitary axis was between 10.2% and 97.7% (I2 = 93%), while the range of proportions of patients experiencing loss of at least one axis after pituitary surgery was between 0.0% and 36.6% (I2 = 91%). None of the a priori planned subgroup analyses explained the observed heterogeneity associated with deterioration of pituitary function after surgery, and the proportion of patients may be underestimated due to publication bias.
Conclusions: The current systematic review finds that the endocrine effect of pituitary surgery is unclear both in terms of the chance of recovery and in terms of the risk of pituitary failure and hypopituitarism should be considered only a relative indication for surgery. However, the range of effects does include potentially clinically relevant rates of pituitary recovery calling for more systematic collection of data in future studies.
Keywords: Endocrine function; Hypopituitarism; Nonfunctioning pituitary adenoma; Systematic review; Transsphenoidal surgery.
© 2022 S. Karger AG, Basel.
Similar articles
-
Subclinical hemorrhagic nonfunctionning pituitary adenoma: pituitary gland function status, endoscopic endonasal transsphenoidal surgery, and outcomes.Br J Neurosurg. 2023 Jun;37(3):265-271. doi: 10.1080/02688697.2020.1815651. Epub 2020 Sep 8. Br J Neurosurg. 2023. PMID: 32896169
-
Axis-specific analysis and predictors of endocrine recovery and deficits for non-functioning pituitary adenomas undergoing endoscopic transsphenoidal surgery.Pituitary. 2020 Aug;23(4):389-399. doi: 10.1007/s11102-020-01045-z. Pituitary. 2020. PMID: 32388803
-
Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.J Neurosurg. 2016 Mar;124(3):589-95. doi: 10.3171/2015.1.JNS141543. Epub 2015 Aug 7. J Neurosurg. 2016. PMID: 26252454
-
The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomas.Endocrine. 2023 Aug;81(2):340-348. doi: 10.1007/s12020-023-03400-z. Epub 2023 May 24. Endocrine. 2023. PMID: 37222882 Free PMC article. Review.
-
Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis.Acta Neurochir (Wien). 2018 May;160(5):1005-1021. doi: 10.1007/s00701-017-3438-z. Epub 2018 Jan 6. Acta Neurochir (Wien). 2018. PMID: 29307020 Free PMC article. Review.
Cited by
-
Post-Operative Medium- and Long-Term Endocrine Outcomes in Patients with Non-Functioning Pituitary Adenomas-Machine Learning Analysis.Cancers (Basel). 2023 May 16;15(10):2771. doi: 10.3390/cancers15102771. Cancers (Basel). 2023. PMID: 37345108 Free PMC article.
-
Factors affecting hormonal outcomes in patients undergoing surgery for non-functioning pituitary neuroendocrine tumors: a prospective observational study.Neurosurg Rev. 2024 Dec 27;48(1):4. doi: 10.1007/s10143-024-03150-0. Neurosurg Rev. 2024. PMID: 39725802
-
Hypopituitarism in non-neuroendocrine pituitary tumors: a systematic review.Rev Endocr Metab Disord. 2025 Aug;26(4):641-657. doi: 10.1007/s11154-025-09969-2. Epub 2025 May 13. Rev Endocr Metab Disord. 2025. PMID: 40360862 Review.
-
Indocyanine green fluorescence in endoscopic transsphenoidal resection of pituitary neuroendocrine tumors: a systematic review.Acta Neurochir (Wien). 2025 Mar 28;167(1):92. doi: 10.1007/s00701-025-06500-z. Acta Neurochir (Wien). 2025. PMID: 40152999 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical